← Back to patent-cliff list
Carotegrast methyl
Tier C — Watch / tradeCarotegrast methyl
Ea Pharma
Originator
2022
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ITGA4&ITGB1, ITGA4&ITGB7
Brand：Carogra
Indications (approved)：Ulcerative colitis
Regional status
US
-
EU
-
China
-
Japan
Approved
2022-03-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Carotegrast methyl?
Approved indications include: Ulcerative colitis.
When does the Carotegrast methyl patent expire?
No public expiry year is available for Carotegrast methyl yet; this page updates once verified.
How do I get a quote for Carotegrast methyl intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01